Hi Buildit - Here are my 2 cents as to why GNBT share price

New Post Public Reply Private Reply Replies (1) Message Board
Paul Jackson Buildit #19133
385
Hi Buildit - Here are my 2 cents as to why GNBT share price is so low, but NGIO's share price can be high -

1. GNBT has issued many shares out - convertible note holders, Veneto/CM...those people own thousands/millions of shares...NGIO spin off is either not happening fast enough for them or they don't believe that would happen easily, so they sell GNBT shares so they can have cash. So far, not too many NGIO shares have been issued...so less possibility of people dumping NGIO shares...

2. It does seem to me some folks want to keep the GNBT PPS low...they can do that on OTC, but will not be able (or will have a hard time) to do that on a major exchange..since NGIO will be spun off to a major exchange, NGIO's PPS should be more in line with its true valuation.

3. GNBT has lots hair on it...some people don't feel comfortable owning GNBT shares...so demand is low....but NGIO does not have any hair on it, demand for those shares will be there especially with vaccine and 10 year efficacy data on breast cancer.

4. Herd mentality - people like to chase stocks that go up...GNBT's PPS has suffered much in the past (bad actors selling when they should not have been selling)...so, GNBT is not a stock of choice right now especially when other stocks are going up daily...why own GNBT when you can't see immediate PPS increase when you can own/trade other hot stocks.

I do think our patience will be paid off eventually...I am hoping by the end of the 2020 at least -

A few things that can propel PPS in the near term
1. BARDA/Health Canada/Malaysia funding
2. China Swine Flu Contract
3. China pays the $1 million and reimburse all covid vaccine development costs
4. GNBT S1s approved
5. NGIO S1s filed
6. Great test results of peptides against infected blood
7. FDA approves - Covid vaccine can start trial 1/2

A couple things that can shoot up PPS in 3-6 months
1. Successful covid vaccine
2. NGIO spins off

Comments/thoughts anyone? Thanks!






Buildit wrote -

Hey, Hoops!

I've sort of run thru a simple analysis of GNBT shares as they relate to NGIO shares a couple of times, and here's my thinking.

1) IF NGIO can get uplisted above $4/sh with 400MM shares (I still don't quite understand why it wasn't 200MM shares, even if we then ended up at $8/sh... but that's a different discussion), that implies a value of $1.6B for NGIO.

2) Let's presume GNBT ends up at 100MM shares OS after paying the bills post-NGIO spin.

3) GNBT keeps 70% of NGIO shares or 280MM shares.

4) This means that each share of GNBT would effectively "own" 2.8 shares of NGIO. That is $11.20 worth of a measurable, liquid asset.

5) So IF the market sees enough value to keep the NGIO shares at or above $4, I fail to see how GNBT shares would remain below $5 and not uplist... unless the market somehow thinks the GNBT assets have a hugely NEGATIVE value.


All that said, I still have a hard time seeing how there is somehow $1.56B ($1.6B less our current GNBT market cap) in value that will be unlocked simply by spinning off NGIO and listing on a major exchange. I've asked the board this Q before. Is simply allowing institutional buyers to participate all it takes to perform that magical release of pent-up value?


Otherwise, someone could come in now and buy GNBT shares to make a killing (as we're all hoping to do).

Currently, if we say GNBT assets are worth $0, the value of a share of NGIO is valued as follows:

1) ~80MM shares of GNBT own ~360MM shares of NGIO (rounding to 90%... I think it's closer to 91%). So each share of GNBT currently "owns" 4.5 shares of NGIO.

2) GNBT share price is $0.52. So $0.52/4.5 = an implied value of $0.1156/sh for NGIO.

3) If you apply a part of the $0.52 to GNBT assets, the implied value of each NGIO share only gets lower.


As I've said before, I think it is a HUGE stretch to fathom how an asset that is currently valued at about a dime is somehow worth $4+ when the uplist happens. And yet here I sit holding... and hoping... which I know is a terrible investment strategy.

Anyone else have insight/wisdom?




Read More: https://investorshangout.com/post/newpost/622...z6TcvOJpz2

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 114

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 108

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 92

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 207

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 37

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 27

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 159

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 52

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 95

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 93

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading

Top 5 Most Recently Viewed Articles

Jefferies Reports Optimism for Vertiv's Future Growth Potential

Updated Category News Views 95

Jefferies Boosts Vertiv Holdings Co. Stock Outlook Recently, Vertiv Holdings Co. (NYSE: VRT), known for its vital role in digital infrastructure and continuity solutions, captured attention with its promising assessment by Jefferies, a prominent financial firm. Jefferies has initiated coverage on Vertiv with a favorable Buy rating, establishing an ambitious price target...

Continue Reading
BioAdaptives: A New Era Ahead Post-Reverse Stock Split

Updated Category News Views 212

Transforming BioAdaptives for a Brighter Future In a recent update, BioAdaptives, Inc. has provided shareholders with insights regarding a key decision that impacts its future direction. After experiencing significant growth in the number of its outstanding shares without corresponding revenue growth, management recognizes the urgent need for a strategic pivot. The...

Continue Reading
Explore Spacious Model Homes at The Timbers for Active Adults

Updated Category News Views 49

Introducing The Timbers at Everlands Lennar, a prominent name in homebuilding, is excited to announce the grand opening of new model homes at The Timbers at Everlands, an innovative community tailored for active adults. These stunning homes offer three distinct styles as well as numerous amenities that cater to comfort and lively living. A Vibrant Community for Active...

Continue Reading
Emerging Innovations in the Tire Technologies Market

Updated Category News Views 410

The Evolution of Tire Technologies in a New Era As electric vehicles (EVs) transform the world of transportation, the tire sector is witnessing a crucial revolution. Gone are the days when tires were merely black rubber circles; today, they are integral to vehicle performance, providing not just grip but also intelligence. With innovations in tire design and technology,...

Continue Reading
Streamlined Emergency Cash Options: Wizzay's New Features

Updated Category News Views 209

Introducing Wizzay's 1-Hour Payday Loans In today's fast-paced world, unexpected expenses can arise at any moment. Wizzay has rolled out a groundbreaking solution for those looking for quick access to funds: 1-hour payday loans that don't involve hard credit checks. This new program is tailored for individuals who require immediate financial assistance, with many...

Continue Reading